Learn More
Medchemexpress LLC EX229, a benzimidazole derivative | 1219739-36-2 | MFCD31696597 | 99.4% | 431.87 | C24H18ClN3O3 | 5 MG

Supplier: Medchemexpress LLC HY1127695MG
EX229 is a benzimidazole-derived small-molecule allosteric activator of AMP-activated protein kinase (AMPK) used for biochemical and cellular research. It binds AMPK complexes with submicromolar affinity and shows potent cellular activity, suitable for pathway and metabolic studies.
- Potent allosteric activator of AMPK (Kd ≈ 0.06 μM for primary complexes).
- Demonstrated cellular activity (EC50 ≈ 3 nM in Sf21 cell assay).
- High purity (≈99.4%).
- Soluble in DMSO (~13 mg/mL) with recommended in vivo formulation protocols.
- Stable as powder and in solvent when stored under recommended conditions.
- Available in small-mass packs and DMSO solutions for screening workflows.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.